Nipro Corporation Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2018 and Year Ending March 31, 2019
May 09, 2018
Share
Nipro Corporation reported consolidated and non-consolidated earnings results for the year ended March 31, 2018. For the year, on consolidated basis, the company reported net sales of JPY 395,397 million compared to JPY 359,699 million a year ago. Operating profit was JPY 27,088 million compared to JPY 28,770 million a year ago. Ordinary profit was JPY 22,684 million compared to JPY 23,166 million a year ago. Profit before income taxes was JPY 17,026 million compared to JPY 18,324 million a year ago. Profit attributable to owners of parent was JPY 11,829 million or JPY 64.51 per diluted share compared to JPY 11,346 million or JPY 61.33 per diluted share a year ago. Net cash provided by operating activities was JPY 41,046 million compared to JPY 33,472 million a year ago.
For the year, on non-consolidated basis, the company reported total net sales of JPY 270,844 million compared to JPY 248,812 million a year ago. Operating profit was JPY 15,426 million compared to JPY 16,209 million a year ago. Ordinary profit was JPY 16,542 million compared to JPY 16,766 million a year ago. Profit before income taxes was JPY 15,453 million compared to JPY 13,927 million a year ago. Profit was JPY 12,272 million or JPY 66.92 per diluted share compared to JPY 12,130 million or JPY 65.57 per diluted share a year ago.
The company provided consolidated earnings guidance for the six months ending September 30, 2018 and year ending March 31, 2019. For the six months ending September 30, 2018, the company expects net sales of JPY 208,600 million, operating income of JPY 9,899 million, ordinary income of JPY 8,200 million and profit attributable to owners of parent of JPY 5,200 million or JPY 31.25 per share.
For the year ending March 31, 2019, the company expects net sales of JPY 426,800 million, operating income of JPY 23,400 million, ordinary income of JPY 20,400 million and profit attributable to owners of parent of JPY 14,200 million or JPY 85.33 per share.
NIPRO CORPORATION is a manufacturer of medical devices, pharmaceuticals and instrument products. The Company has three segments. The Medical-Related segment involves in the sale of injections and infusions, artificial organs, high function and dialysis related medical equipment, and diabetes, generics and kits related medicine products in Japan, as well as the sales of medical devices for injection and infusion, artificial organs and diabetes in overseas markets. The Pharmaceutical-Related segment involves in the manufacture and sale of pharmaceuticals. The Pharma Packaging segment sells glass for vials and ampoules as medical glass in Japan, thermos glass for lighting and glass for lighting equipment.
Nipro Corporation Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2018 and Year Ending March 31, 2019